Details For Selected Brain Tumor Treatment
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase: Phase 1/2
Treatment ID#: 1805         NABTC 05-02
Age Group: Adults Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Recurrent Glioblastoma Multiforme or Gliosarcoma
Last Updated: 04/15/2008
Tumor Types: Glioblastoma Multiforme
Gliosarcoma
Comments: BAY 43-9006 (sorafenib) blocks the vascular endothelial growth factor receptor (VEGF-R) and a protein in an important tumor growth pathway (B-raf). CCI-779 (temsirolimus) blocks a specific protein, mTOR, which is important in pathways that promote tumor growth. R115777 (tipifarnib) blocks an important process called farnesylation that activates proteins for several important tumor growth pathways. OSI-774 (erlotinib) blocks the epidermal growth factor receptor (EGF-R). Combining two drugs that block these factors and receptors may provide better tumor control than a single drug. This study will also determine the relationship between biomarkers in the tumor and patient`s blood with patient response.
Treatment Type: Less-Toxics
Immunological, Biological or Targeted Therapy
Contact: Clinical Trials Office - Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center
Dana Farber Cancer Institute

Boston, MA 02115 USA
Phone: 617-582-8480
Fax:
E-mail:
Website:
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites